|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
multiple interactions |
EXP |
AIFM1 protein inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased reduction of Glutathione]; AIFM1 protein promotes the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased reduction of Adenine Nucleotides] |
CTD |
PMID:15316071 |
|
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]]; Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]; wortmannin promotes the reaction [Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of AKT1 protein]] |
CTD |
PMID:21138475 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
AQP3 |
aquaporin 3 (Gill blood group) |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of AQP3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
|
|
G |
BAD |
BCL2 associated agonist of cell death |
decreases phosphorylation multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of BAD protein Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of BAD protein] |
CTD |
PMID:21138475 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in increased expression of BAX protein Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased expression of BAX protein] |
CTD |
PMID:21138475 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression |
ISO |
Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein] S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 mRNA; S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein |
CTD |
PMID:17135264 PMID:21138475 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
CALCA |
calcitonin related polypeptide alpha |
multiple interactions increases secretion |
ISO |
Carbon Dioxide inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased secretion of CALCA protein] |
CTD |
PMID:18052948 |
|
NCBI chr11:14,966,668...14,972,351
Ensembl chr11:14,966,622...14,972,354
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased activity of and results in increased cleavage of CASP1 protein |
CTD |
PMID:10903723 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases activity decreases activity |
EXP ISO |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of CASP3 protein] S-Nitroso-N-Acetylpenicillamine results in increased activity of CASP3 protein S-Nitroso-N-Acetylpenicillamine results in decreased activity of CASP3 protein Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased activity of CASP3 protein] |
CTD |
PMID:10811113 PMID:12006578 PMID:12220328 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CREB1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [3,5-dimethoxy-4'-hydroxystilbene results in decreased phosphorylation of CREB1 protein]; S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Quercetin results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:17135264 |
|
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
|
|
G |
CSRP3 |
cysteine and glycine rich protein 3 |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of CSRP3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr11:19,182,030...19,201,983
Ensembl chr11:19,182,030...19,210,571
|
|
G |
DRGX |
dorsal root ganglia homeobox |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of DRGX mRNA |
CTD |
PMID:12102619 |
|
NCBI chr10:49,364,066...49,396,089
Ensembl chr10:49,364,066...49,396,089
|
|
G |
EDN1 |
endothelin 1 |
increases secretion |
ISO |
S-Nitroso-N-Acetylpenicillamine results in increased secretion of EDN1 protein |
CTD |
PMID:15640287 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
ELN |
elastin |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of ELN mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 7:74,028,173...74,069,907
Ensembl chr 7:74,027,789...74,069,907
|
|
G |
EXOC6 |
exocyst complex component 6 |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of SEC15 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr10:92,826,831...93,059,490
Ensembl chr10:92,826,831...93,059,493
|
|
G |
FASLG |
Fas ligand |
multiple interactions |
EXP |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [Etoposide results in increased activity of FASLG promoter]; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine results in increased activity of FASLG promoter] |
CTD |
PMID:10811113 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FCGR2A |
Fc gamma receptor IIa |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of FCGR3 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
|
|
G |
FCGR2B |
Fc gamma receptor IIb |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of FCGR2B mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 1:161,647,243...161,678,654
Ensembl chr 1:161,663,143...161,678,654
|
|
G |
FGF2 |
fibroblast growth factor 2 |
multiple interactions |
EXP |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] |
CTD |
PMID:16351512 |
|
NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
|
|
G |
GHRH |
growth hormone releasing hormone |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of GHRH mRNA |
CTD |
PMID:12102619 |
|
NCBI chr20:37,251,086...37,261,814
Ensembl chr20:37,251,086...37,261,819
|
|
G |
GNAI2 |
G protein subunit alpha i2 |
multiple interactions decreases expression |
ISO |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]; Uric Acid inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
|
|
G |
GNAI3 |
G protein subunit alpha i3 |
multiple interactions decreases expression |
ISO |
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]; Uric Acid inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 1:109,548,615...109,600,195
Ensembl chr 1:109,548,615...109,600,195
|
|
G |
GOT1 |
glutamic-oxaloacetic transaminase 1 |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of GOT1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein]]; GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein]]; GPX1 protein affects the susceptibility to [Diquat co-treated with S-Nitroso-N-Acetylpenicillamine]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased expression of GPX1 protein] |
CTD |
PMID:11672444 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSTA2 |
glutathione S-transferase alpha 2 |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine co-treated with 2-tert-butylhydroquinone] results in increased expression of GSTA2 |
CTD |
PMID:15357004 |
|
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
|
|
G |
HCK |
HCK proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of HCK mRNA |
CTD |
PMID:12102619 |
|
NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in increased expression of HMOX1 protein |
CTD |
PMID:16439612 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [Streptozocin results in increased expression of IFNG protein] |
CTD |
PMID:15892581 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
ITPKA |
inositol-trisphosphate 3-kinase A |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of ITPKA mRNA |
CTD |
PMID:12102619 |
|
NCBI chr15:41,493,874...41,503,551
Ensembl chr15:41,493,393...41,503,551
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
decreases expression multiple interactions increases phosphorylation decreases phosphorylation |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MAPK1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:15640287 PMID:19252090 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
decreases expression decreases phosphorylation increases phosphorylation multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MAPK3 protein S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK3 protein S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK3 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of MAPK3 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:15640287 PMID:19252090 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MME |
membrane metalloendopeptidase |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of MME mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
|
|
G |
MTF1 |
metal regulatory transcription factor 1 |
affects localization |
ISO |
S-Nitroso-N-Acetylpenicillamine affects the localization of MTF1 protein |
CTD |
PMID:16423564 |
|
NCBI chr 1:37,809,574...37,859,592
Ensembl chr 1:37,809,574...37,859,592
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of NFKB1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NOS2 |
nitric oxide synthase 2 |
decreases activity decreases expression |
EXP ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased activity of NOS2 protein S-Nitroso-N-Acetylpenicillamine results in decreased expression of NOS2 promoter |
CTD |
PMID:11076874 PMID:15565661 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NPPA |
natriuretic peptide A |
multiple interactions |
ISO |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:11799084 |
|
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
|
|
G |
NPR3 |
natriuretic peptide receptor 3 |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of NPR3 protein] |
CTD |
PMID:16962941 PMID:19252090 |
|
NCBI chr 5:32,690,872...32,791,720
Ensembl chr 5:32,689,070...32,791,724
|
|
G |
OPRM1 |
opioid receptor mu 1 |
multiple interactions |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RAF1 protein]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein] |
CTD |
PMID:18652891 PMID:21235400 |
|
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
|
|
G |
PAM |
peptidylglycine alpha-amidating monooxygenase |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of PAM mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 5:102,754,783...103,031,105
Ensembl chr 5:102,753,981...103,029,730
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] inhibits the reaction [N-caproylsphingosine promotes the reaction [CASP3 protein results in increased cleavage of PARP1 protein]] |
CTD |
PMID:10811113 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PRKCA |
protein kinase C alpha |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCA protein] |
CTD |
PMID:18652891 |
|
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
|
|
G |
PRKCG |
protein kinase C gamma |
multiple interactions |
ISO |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to PRKCG protein] |
CTD |
PMID:18652891 PMID:21235400 |
|
NCBI chr19:53,881,094...53,907,652
Ensembl chr19:53,879,190...53,907,652
|
|
G |
PRKG1 |
protein kinase cGMP-dependent 1 |
multiple interactions increases activity |
ISO |
[S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] S-Nitroso-N-Acetylpenicillamine results in increased activity of PRKG1 protein |
CTD |
PMID:11799084 |
|
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
|
|
G |
PTPN1 |
protein tyrosine phosphatase non-receptor type 1 |
increases activity |
ISO |
SNAP increases activity of Ptpn1 protein in aortic smooth muscle cells |
RGD |
PMID:10484424 |
RGD:401965470 |
NCBI chr20:50,510,383...50,585,241
Ensembl chr20:50,510,321...50,585,241
|
|
G |
RACK1 |
receptor for activated C kinase 1 |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of RACK1 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr 5:181,236,897...181,243,906
Ensembl chr 5:181,236,897...181,248,096
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RAF1 protein] |
CTD |
PMID:21235400 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,582,101...12,664,201
|
|
G |
RGS17 |
regulator of G protein signaling 17 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein] |
CTD |
PMID:18652891 |
|
NCBI chr 6:153,004,459...153,131,282
Ensembl chr 6:153,004,459...153,131,282
|
|
G |
RPLP0 |
ribosomal protein lateral stalk subunit P0 |
decreases expression |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of RPLP0 mRNA |
CTD |
PMID:12102619 |
|
NCBI chr12:120,196,699...120,201,111
Ensembl chr12:120,196,699...120,201,235
|
|
G |
SFTPA1 |
surfactant protein A1 |
decreases expression multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPA1 mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr10:79,610,939...79,615,455
Ensembl chr10:79,610,939...79,615,455
|
|
G |
SFTPB |
surfactant protein B |
multiple interactions decreases expression |
ISO |
bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPB mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPB mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
|
|
G |
SFTPC |
surfactant protein C |
multiple interactions decreases expression |
ISO |
bosentan inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPC mRNA]; PD 156707 inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of SFTPC mRNA] |
CTD |
PMID:15640287 |
|
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions affects response to substance |
ISO |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in decreased activity of SOD1 protein] SOD1 protein affects the susceptibility to S-Nitroso-N-Acetylpenicillamine |
CTD |
PMID:10698074 PMID:11672444 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
GPX1 protein affects the reaction [S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein]]; S-Nitroso-N-Acetylpenicillamine promotes the reaction [Diquat results in increased activity of SOD2 protein] [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of and results in increased activity of SOD2 protein; [S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of SOD2 mRNA |
CTD |
PMID:11672444 PMID:14996425 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
ISO EXP |
[S-Nitroso-N-Acetylpenicillamine results in increased abundance of Nitric Oxide] which results in increased expression of TRP53 mRNA S-Nitroso-N-Acetylpenicillamine promotes the reaction [FGF2 protein results in increased expression of TP53 protein] |
CTD |
PMID:7673702 PMID:16351512 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TRPC6 |
transient receptor potential cation channel subfamily C member 6 |
multiple interactions |
ISO |
S-Nitroso-N-Acetylpenicillamine inhibits the reaction [1-oleoyl-2-acetylglycerol results in increased activity of TRPC6 protein] |
CTD |
PMID:20177073 |
|
NCBI chr11:101,451,564...101,584,007
Ensembl chr11:101,451,564...101,872,562
|
|
G |
VASP |
vasodilator stimulated phosphoprotein |
increases phosphorylation |
ISO |
S-Nitroso-N-Acetylpenicillamine results in increased phosphorylation of VASP protein |
CTD |
PMID:11799084 |
|
NCBI chr19:45,507,479...45,526,983
Ensembl chr19:45,506,579...45,526,989
|
|
G |
VEGFA |
vascular endothelial growth factor A |
increases expression increases secretion |
ISO |
S-Nitroso-N-Acetylpenicillamine results in increased expression of VEGFA mRNA S-Nitroso-N-Acetylpenicillamine results in increased secretion of VEGFA protein |
CTD |
PMID:10613739 |
|
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|